These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36119468)

  • 1. Efficacy and safety of taxanes combined with chemotherapy drugs in advanced triple negative breast cancer: A meta-analysis of 26 randomized controlled trials.
    Huang Q; Mei Z; Han X
    Front Oncol; 2022; 12():972767. PubMed ID: 36119468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis.
    Lin C; Cui J; Peng Z; Qian K; Wu R; Cheng Y; Yin W
    Eur J Med Res; 2022 Oct; 27(1):201. PubMed ID: 36242046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified xiaoyao san combined with chemotherapy for breast cancer: A systematic review and meta-analysis of randomized controlled trials.
    Pan J; Fu S; Zhou Q; Lin D; Chen Q
    Front Oncol; 2023; 13():1050337. PubMed ID: 37035186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of combination chemotherapy regimens containing taxanes for first-line treatment in advanced gastric cancer.
    Ma X; Zhang Y; Wang C; Yu J
    Clin Exp Med; 2023 Jun; 23(2):381-396. PubMed ID: 35428957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response.
    Tan Y; Wang H; Xu B; Zhang X; Zhu G; Ge Y; Lu T; Gao R; Li J
    Front Pharmacol; 2022; 13():977708. PubMed ID: 36091754
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
    Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of Chinese herbal injections in combination with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of 140 randomized controlled trials.
    Cao K; Hu S; Wang D; Qiao C; Wang Z; Wang J; Hou W
    Front Oncol; 2024; 14():1307836. PubMed ID: 38371619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safety.
    Sharmni Vishnu K; Win TT; Aye SN; Basavaraj AK
    BMC Cancer; 2022 Nov; 22(1):1139. PubMed ID: 36335316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Qiao C; Hu S; Wang D; Cao K; Wang Z; Wang X; Ma X; Li Z; Hou W
    Front Oncol; 2023; 13():1198768. PubMed ID: 37731634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis.
    Xie R; Huang H; Chen T; Huang X; Chen C
    Front Pharmacol; 2023; 14():1228225. PubMed ID: 37829303
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
    Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis.
    Xun X; Ai J; Feng F; Hong P; Rai S; Liu R; Zhang B; Zhou Y; Hu H
    Front Pharmacol; 2023; 14():1108772. PubMed ID: 36794276
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials.
    Liang Z; Liu L; Li W; Lai H; Li L; Wu J; Zhang H; Fang C
    Front Oncol; 2023; 13():1258347. PubMed ID: 37886169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of taxane and anthracycline combination regimens in the management of advanced breast cancer: a meta-analysis of randomized trials.
    Zheng R; Han S; Duan C; Chen K; You Z; Jia J; Lin S; Liang L; Liu A; Long H; Wang S
    Medicine (Baltimore); 2015 May; 94(17):e803. PubMed ID: 25929935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis.
    Lei L; Chen R; Fan L; Zheng W; Wang X
    Ann Palliat Med; 2022 Jul; 11(7):2382-2394. PubMed ID: 35927773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients: A PRISMA-compliant systematic review with meta-analysis and meta-regression.
    An N; Zhang Y; Niu H; Li Z; Cai J; Zhao Q; Li Q
    Medicine (Baltimore); 2016 Dec; 95(50):e5601. PubMed ID: 27977598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of efficacy and safety for compound kushen injection combined with intraperitoneal chemotherapy for patients with malignant ascites: A systematic review and meta-analysis.
    Yu HB; Hu JQ; Han BJ; Cao HJ; Chen ST; Chen X; Xiong HT; Gao J; Du YY; Zheng HG
    Front Pharmacol; 2023; 14():1036043. PubMed ID: 36937874
    [No Abstract]   [Full Text] [Related]  

  • 19. The Safety and Effectiveness of Bevacizumab in the Treatment of Nonsquamous Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.
    Zhou Y; He M; Li R; Peng Y; Li F; Li S; Yang M
    Biomed Res Int; 2021; 2021():5537899. PubMed ID: 34532503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Combination Therapy With PD-1/PD-L1, BRAF, and MEK Inhibitor for Stage III-IV Melanoma: A Systematic Review and Meta-Analysis.
    Liu Y; Zhang X; Wang G; Cui X
    Front Oncol; 2021; 11():693655. PubMed ID: 34195094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.